3rd Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Period 3rd Quarter 2009 Filed Oct 26, 2009 Signed by Jerome L. Steffl, V.P., Government Affairs

Official filing
Firm
PRIME THERAPEUTICS
Client
PRIME THERAPEUTICS
Income
—
Expenses
$52,597
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Insurance INS

S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting

LobbyistCovered position, as disclosed
JERRY STEFFL —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3200 (111th), H.R. 1427 (111th), S. 1796 (111th), S. 1697 (111th), H.R. 1549 (111th), S. 726 (111th), H.R. 1204 (111th)

Health Issues HCR

S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting

LobbyistCovered position, as disclosed
JERRY STEFFL —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1549 (111th), S. 1697 (111th), H.R. 1427 (111th), H.R. 1204 (111th), S. 726 (111th), H.R. 3200 (111th), S. 1796 (111th)

Pharmacy PHA

S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting

LobbyistCovered position, as disclosed
JERRY STEFFL —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1204 (111th), S. 1697 (111th), H.R. 3200 (111th), H.R. 1549 (111th), S. 1796 (111th), H.R. 1427 (111th), S. 726 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.